Ketorolac Tromethamine
NDC 85766-035, Ketorolac Tromethamine, tablet, film coated, from Sportpharm LLC.
- Product NDC
- 85766-035
- Status
- Listed
- Labeler
- Sportpharm LLC
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA074754
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/85766-035 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- KETOROLAC TROMETHAMINE10 mg/1
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitor [EPC]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 85766-035-00 | 85766003500 | 1 TABLET, FILM COATED in 1 BOTTLE (85766-035-00) |
| 85766-035-01 | 85766003501 | 100 TABLET, FILM COATED in 1 BOTTLE (85766-035-01) |
| 85766-035-02 | 85766003502 | 2 TABLET, FILM COATED in 1 BOTTLE (85766-035-02) |
| 85766-035-03 | 85766003503 | 3 TABLET, FILM COATED in 1 BOTTLE (85766-035-03) |
| 85766-035-06 | 85766003506 | 6 TABLET, FILM COATED in 1 BOTTLE (85766-035-06) |
| 85766-035-10 | 85766003510 | 10 TABLET, FILM COATED in 1 BOTTLE (85766-035-10) |
| 85766-035-14 | 85766003514 | 14 TABLET, FILM COATED in 1 BOTTLE (85766-035-14) |
| 85766-035-20 | 85766003520 | 20 TABLET, FILM COATED in 1 BOTTLE (85766-035-20) |
| 85766-035-30 | 85766003530 | 30 TABLET, FILM COATED in 1 BOTTLE (85766-035-30) |
| 85766-035-60 | 85766003560 | 60 TABLET, FILM COATED in 1 BOTTLE (85766-035-60) |
| 85766-035-90 | 85766003590 | 90 TABLET, FILM COATED in 1 BOTTLE (85766-035-90) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0749f61d-12e6-4280-8f41-bd4df81e7ae6
Use it
Look up 85766-035 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/85766-035 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 85766-035. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.